Congress Materials – Florida Society of Rheumatology (FSR 2026)
2026 Florida Society of Rheumatology| Jul 16-19 | Orlando, FL
Achievement of DAPSA/cDAPSA Low Disease Activity With Guselkumab in Active and Erosive Psoriatic Arthritis Across Participant Subgroups in APEX
Christopher T Ritchlin, Laura C Coates, Philip J Mease, Alexa P Kollmeier, Weihong Hu, Soumya D Chakravarty, Stacey Fitch, Karissa Lozenski, Alexis Ogdie, Proton Rahman
APEX: Durable Inhibition of Structural Damage Progression and Improvements in Joint Disease Activity Over 48Weeks With Guselkumab in Active and Erosive Psoriatic Arthritis
Christopher T Ritchlin, Philip J Mease, Laura C Coates, Alexa P Kollmeier, Bei Zhou, Yusang Jiang, Karen Bensley, Koeun Im, Rattandeep Batra, Karissa Lozenski, Steven Fakharzadeh, Soumya D Chakravarty, Proton Rahman, Désirée van der Heijde
Efficacy and Safety of Guselkumab in Active Psoriatic Arthritis With Inadequate Response/Intolerance to One Prior TNF Inhibitor Through 1 Year of the SOLSTICE Study
Alice B Gottlieb, Joseph F Merola, Philip J Mease, Christopher T Ritchlin, Jose U Scher, Kimberly Parnell Lafferty, Soumya D Chakravarty, Yanli Wang, Yevgeniy Krol, Stacey Fitch, Alexis Ogdie
Guselkumab Response and Inhibition of Structural Damage Progression in Active Psoriatic Arthritis Across APEX Participant Subgroups
Philip J Mease, Christopher T Ritchlin, Laura C Coates, Alexa P Kollmeier, Bei Zhou, Yusang Jiang, Karen Bensley, Koeun Im, Rattandeep Batra, Karissa Lozenski, Soumya D Chakravarty, Proton Rahman, Désirée van der Heijde
Icotrokinra in Moderate-to-Severe Plaque Psoriasis and Psoriatic Arthritis: Pooled Analysis of the Phase 3 ICONIC-LEAD, ICONIC-ADVANCE 1, and ICONIC-ADVANCE 2 Trials
Iain B. McInnes, Linda Stein Gold, Robert Bissonnette, Mark G. Lebwohl, Ofelia Reyes-Servin, Joseph Cafone, Ya-Wen Yang, Soumya D. Chakravarty, Charles Iaconangelo, Shu Li, Tasneam Shagroni, Karissa Lozenski, April W. Armstrong, Joseph F. Merola
Real-World On-Label Treatment Persistence Through 24 Months in Biologic-Naïve and Biologic-Experienced Patients with PsA: Guselkumab versus tsDMARDs
Philip J Mease, Jessica Walsh, Timothy P Fitzgerald, Soumya D. Chakravarty, Elizabeth Adamson, Pavithra Srinivas, Bruno Emond, Arthur Voegel, Yuxi Wang, Sinia Sareen, Helena Huang, Patrick Lefebvre, Dominic Pilon, Shikha Singla, Joseph F Merola
Copies of these presentations are for personal use only and may not be reproduced without written permission from the presentation author.
Connect with us
Connect with us
Would you like to clear and leave your conversation? Message history will be lost.